ArticleEpilepsia2022

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial.

Mark Kristof Farkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.